Status:

COMPLETED

Social Safety Learning in the Brain Oxytocin System

Lead Sponsor:

University of Washington

Conditions:

Social Phobia

Eligibility:

All Genders

18-45 years

Phase:

PHASE2

Brief Summary

The investigators are conducting this research study to examine whether oxytocin enhances social safety learning (learning safety through the experience of another individual) in people with social an...

Detailed Description

The goal of the current study is to examine the potential role of oxytocin in enhancing social learning in SAD. The investigators' primary hypothesis is that vicarious extinction learning will contrib...

Eligibility Criteria

Inclusion

  • For Clinical Sample
  • Men and women age 18-45
  • Women must be having regular menstrual cycles and not be taking oral contraception
  • Primary diagnosis of social anxiety disorder
  • For Healthy Sample
  • Men and women age 18-45
  • Women must be having regular menstrual cycles and not be taking oral contraception
  • No current or lifetime history of psychiatric, neurological, or medical disorders

Exclusion

  • For All Groups
  • Pregnancy or breastfeeding
  • Positive urine drug screening test result
  • History of nasal pathology
  • Current use of any psychotropic medication or steroids
  • Active substance use disorder within the past 6 months
  • History of serious medical illnesses or untreated endocrine diseases
  • History of head injury, neurological disorder, or neurosurgical procedure
  • Positive magnetic resonance (MR) screen
  • For Clinical Sample
  • Lifetime diagnoses of mania or psychotic disorder based on the Diagnostic and Statistical Manual (DSM- 5th ed)
  • Acute suicidal ideation
  • For Healthy Sample
  • Lifetime DSM-5 diagnosis of any medical, neurological, or psychiatric illness

Key Trial Info

Start Date :

June 26 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 30 2024

Estimated Enrollment :

121 Patients enrolled

Trial Details

Trial ID

NCT05968651

Start Date

June 26 2023

End Date

September 30 2024

Last Update

December 13 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Washington

Seattle, Washington, United States, 98195